Recent Updates
Recently added Catalysts
GOSS Negative Sentiment

Please visit again. “Live at Congress” is currently under construction. While we work to add content, we invite you to browse and explore other sections of our website. Thank you for your patience! The Gossamer Bio Team.

Wednesday, October 1, 2025 BiopharmaWatch Research 2 min read
Add on Google
Key Takeaway: Gossamer Bio has announced that their 'Live at Congress' section is under construction, inviting users to explore other areas of their website in the meantime. The message indicates a lack of available content and does not provide a timeline for when the section will be operational. This may lead to frustration among users seeking updates.
Price reaction · baseline $2.62 (2025-10-01T15:31:00.000Z) · hit during market hours · clean, no other GOSS news in the window
day 0 close · peak
-5%

Market Sentiment Analysis

CONCERNS & RISKS

  • The 'Live at Congress' section is currently under construction.
  • Users may find limited content available on the website.
  • The announcement lacks specific updates or timelines for completion.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
5.9%
average across 2 past catalysts
Cash runway
~4 mo
High dilution risk
Lead asset
GB001
Phase 2 · Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Full Press Release Details

Please visit again. “Live at Congress” is currently under construction. While we work to add content, we invite you to browse and explore other sections of our website. Thank you for your patience! The Gossamer Bio Team.
• About Overview Team Management Board of Directors Collaboration Contact Locations Contact Form Sponsorship Disclosure
• Seralutinib About Seralutinib PAH PH-ILD Posters & Presentations
• Patients Overview Expanded Access
• Investors Overview News Events & Presentations Events Presentations Filings Governance Overview Committee Composition Management Board of Directors Stock Stock Quote & Chart Historical Price Lookup Investment Calculator Analyst Coverage Info FAQs Contact IR Email Alerts
• Careers & Culture Who We Are Open Positions
• Overview
• Team
• Management
• Board of Directors
• Collaboration
• Contact
• Locations
• Contact Form
• Sponsorship Disclosure
• About Seralutinib
• PAH
• PH-ILD
• Posters & Presentations
• Overview
• Expanded Access
• Overview
• News
• Events & Presentations Events Presentations
• Filings
• Governance Overview Committee Composition Management Board of Directors
• Stock Stock Quote & Chart Historical Price Lookup Investment Calculator Analyst Coverage
• Info FAQs Contact IR Email Alerts
• Events
• Presentations
• Overview
• Committee Composition
• Management
• Board of Directors
• Stock Quote & Chart
• Historical Price Lookup
• Investment Calculator
• Analyst Coverage
• FAQs
• Contact IR
• Email Alerts
• Who We Are
• Open Positions

Frequently Asked Questions

What is currently happening with the Live at Congress section?

The Live at Congress section is under construction and not available.

Can I find other information on Gossamer Bio's website?

Yes, users are invited to explore other sections of the website.

Is there a timeline for the Live at Congress completion?

No specific timeline for completion has been provided.

ShareAdd on Google
Tags: GOSS Viatris Investor Conferences Healthcare Gossamer Bio Live at Congress Seralutinib PAH PH-ILD
Last updated: Oct 1, 2025

Biotech snapshot

Cash runway
$57M liquidity · $13M/mo burn
~4 mo
High dilution risk
Lead asset
GB001Phase 2
Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) →

Catalyst track record

+53%
best trade around GOSS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for GOSS.

See every catalyst's timing & PoA →